These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 20671122)
21. Development of functional human NK cells in an immunodeficient mouse model with the ability to provide protection against tumor challenge. Kwant-Mitchell A; Pek EA; Rosenthal KL; Ashkar AA PLoS One; 2009 Dec; 4(12):e8379. PubMed ID: 20027308 [TBL] [Abstract][Full Text] [Related]
22. Human Lymphoid Tissues Harbor a Distinct CD69+CXCR6+ NK Cell Population. Lugthart G; Melsen JE; Vervat C; van Ostaijen-Ten Dam MM; Corver WE; Roelen DL; van Bergen J; van Tol MJ; Lankester AC; Schilham MW J Immunol; 2016 Jul; 197(1):78-84. PubMed ID: 27226093 [TBL] [Abstract][Full Text] [Related]
23. Effect of influenza A infection on umbilical cord blood natural killer function regulation with interleukin-15. Lin SJ; Cheng PJ; Lin TY; Lee PT; Hsiao HS; Kuo ML J Infect Dis; 2012 Mar; 205(5):745-56. PubMed ID: 22262794 [TBL] [Abstract][Full Text] [Related]
24. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. Juelke K; Killig M; Luetke-Eversloh M; Parente E; Gruen J; Morandi B; Ferlazzo G; Thiel A; Schmitt-Knosalla I; Romagnani C Blood; 2010 Aug; 116(8):1299-307. PubMed ID: 20505160 [TBL] [Abstract][Full Text] [Related]
25. Impairment in cytotoxicity and expression of NK cell- activating receptors on human NK cells following exposure to asbestos fibers. Nishimura Y; Miura Y; Maeda M; Kumagai N; Murakami S; Hayashi H; Fukuoka K; Nakano T; Otsuki T Int J Immunopathol Pharmacol; 2009; 22(3):579-90. PubMed ID: 19822075 [TBL] [Abstract][Full Text] [Related]
26. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Mrózek E; Anderson P; Caligiuri MA Blood; 1996 Apr; 87(7):2632-40. PubMed ID: 8639878 [TBL] [Abstract][Full Text] [Related]
27. IL-12 directs further maturation of ex vivo differentiated NK cells with improved therapeutic potential. Lehmann D; Spanholtz J; Sturtzel C; Tordoir M; Schlechta B; Groenewegen D; Hofer E PLoS One; 2014; 9(1):e87131. PubMed ID: 24498025 [TBL] [Abstract][Full Text] [Related]
28. Predominant development of mature and functional human NK cells in a novel human IL-2-producing transgenic NOG mouse. Katano I; Takahashi T; Ito R; Kamisako T; Mizusawa T; Ka Y; Ogura T; Suemizu H; Kawakami Y; Ito M J Immunol; 2015 Apr; 194(7):3513-25. PubMed ID: 25712215 [TBL] [Abstract][Full Text] [Related]
29. Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15. McCullar V; Oostendorp R; Panoskaltsis-Mortari A; Yun G; Lutz CT; Wagner JE; Miller JS Exp Hematol; 2008 May; 36(5):598-608. PubMed ID: 18295962 [TBL] [Abstract][Full Text] [Related]
30. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. Dulphy N; Haas P; Busson M; Belhadj S; Peffault de Latour R; Robin M; Carmagnat M; Loiseau P; Tamouza R; Scieux C; Rabian C; Di Santo JP; Charron D; Janin A; Socié G; Toubert A J Immunol; 2008 Aug; 181(3):2227-37. PubMed ID: 18641363 [TBL] [Abstract][Full Text] [Related]
31. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10. Goodier MR; Londei M J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046 [TBL] [Abstract][Full Text] [Related]
32. CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. Chan A; Hong DL; Atzberger A; Kollnberger S; Filer AD; Buckley CD; McMichael A; Enver T; Bowness P J Immunol; 2007 Jul; 179(1):89-94. PubMed ID: 17579025 [TBL] [Abstract][Full Text] [Related]
33. High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy. Spanholtz J; Tordoir M; Eissens D; Preijers F; van der Meer A; Joosten I; Schaap N; de Witte TM; Dolstra H PLoS One; 2010 Feb; 5(2):e9221. PubMed ID: 20169160 [TBL] [Abstract][Full Text] [Related]
34. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin. Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416 [TBL] [Abstract][Full Text] [Related]
35. Selective expansion and engraftment of human CD16+ NK cells in NOD/SCID mice. Harada H; Suzu S; Ito T; Okada S Eur J Immunol; 2005 Dec; 35(12):3599-609. PubMed ID: 16304638 [TBL] [Abstract][Full Text] [Related]
36. Natural Killer Cells Expanded and Preactivated Exhibit Enhanced Antitumor Activity against Different Tumor Cells in Vitro. Biswas BK; Guru SA; Sumi MP; Jamatia E; Gupta RK; Lali P; Konar BC; Saxena A; Mir R Asian Pac J Cancer Prev; 2020 Jun; 21(6):1595-1605. PubMed ID: 32592353 [TBL] [Abstract][Full Text] [Related]
37. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells. Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057 [TBL] [Abstract][Full Text] [Related]
38. Ex vivo generated natural killer cells acquire typical natural killer receptors and display a cytotoxic gene expression profile similar to peripheral blood natural killer cells. Lehmann D; Spanholtz J; Osl M; Tordoir M; Lipnik K; Bilban M; Schlechta B; Dolstra H; Hofer E Stem Cells Dev; 2012 Nov; 21(16):2926-38. PubMed ID: 22571679 [TBL] [Abstract][Full Text] [Related]
39. IL-7 enhances survival of human CD56bright NK cells. Michaud A; Dardari R; Charrier E; Cordeiro P; Herblot S; Duval M J Immunother; 2010 May; 33(4):382-90. PubMed ID: 20386468 [TBL] [Abstract][Full Text] [Related]
40. The Notch ligands Jagged2, Delta1, and Delta4 induce differentiation and expansion of functional human NK cells from CD34+ cord blood hematopoietic progenitor cells. Beck RC; Padival M; Yeh D; Ralston J; Cooke KR; Lowe JB Biol Blood Marrow Transplant; 2009 Sep; 15(9):1026-37. PubMed ID: 19660715 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]